317
Views
15
CrossRef citations to date
0
Altmetric
Review

The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis

, &
Pages 613-624 | Received 26 Nov 2015, Accepted 23 Feb 2016, Published online: 21 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Aliki I. Venetsanopoulou, Paraskevi V. Voulgari & Alexandros A. Drosos. (2022) Janus kinase versus TNF inhibitors: where we stand today in rheumatoid arthritis. Expert Review of Clinical Immunology 18:5, pages 485-493.
Read now
Priyanka Vashisht & James O’dell. (2017) Not all TNF inhibitors in rheumatoid arthritis are created equal: important clinical differences. Expert Opinion on Biological Therapy 17:8, pages 989-999.
Read now

Articles from other publishers (13)

D. Cela, F. Brignole-Baudouin, A. Labbé & C. Baudouin. (2022) Trabéculum glaucomateux : une trabéculopathie inflammatoire ?. Journal Français d'Ophtalmologie 45:4, pages 455-477.
Crossref
Jeffrey R. Curtis, Soumya D. Chakravarty, Shawn Black, Shelly Kafka, Stephen Xu, Wayne Langholff, Dennis Parenti, Andrew Greenspan & Sergio Schwartzman. (2021) Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study. Rheumatology and Therapy 8:4, pages 1551-1563.
Crossref
D. Cela, F. Brignole-Baudouin, A. Labbé & C. Baudouin. (2021) The trabecular meshwork in glaucoma: An inflammatory trabeculopathy?. Journal Français d'Ophtalmologie 44:9, pages e497-e517.
Crossref
Maria N. Chamurlieva, Yulia L. Korsakova, Stefka G. Radenska-Lopovok & Tatiana V. Korotaeva. (2021) Drug-induced cutaneous vasculitis developing during Etanercept treatment for rheumatoid arthritis. Vestnik dermatologii i venerologii 97:4, pages 113-119.
Crossref
Louise Gaboriau, Jean-Baptiste Davion, Sandrine Combret, Bénédicte Lebrun-Vignes, Fanny Rocher, Franck Rouby, Florence Renaud, Sandrine Morell-Dubois & Sophie Gautier. (2020) Adalimumab and myositis: A case report and review of the French and international Pharmacovigilance Databases. Neuromuscular Disorders 30:11, pages 915-920.
Crossref
Najat J. Ziyadeh, Anja Geldhof, Wim Noël, Marijo Otero-Lobato, Suzan Esslinger, Soumya D. Chakravarty, Yiting Wang & John D. Seeger. (2020) Post-approval Safety Surveillance Study of Golimumab in the Treatment of Rheumatic Disease Using a United States Healthcare Claims Database. Clinical Drug Investigation 40:11, pages 1021-1040.
Crossref
Charles D. Ciccone. 2020. Guccione's Geriatric Physical Therapy. Guccione's Geriatric Physical Therapy 102 136 .
Shinwan Kany, Jan Tilmann Vollrath & Borna Relja. (2019) Cytokines in Inflammatory Disease. International Journal of Molecular Sciences 20:23, pages 6008.
Crossref
Lei Zhang, Jun Yu, Chun Wang & Wei Wei. (2019) The effects of total glucosides of paeony (TGP) and paeoniflorin (Pae) on inflammatory-immune responses in rheumatoid arthritis (RA). Functional Plant Biology 46:2, pages 107.
Crossref
Einav Srulovici, Vishvas Garg, Adi Ghilai, Becca Feldman, Moshe Hoshen, Ran D. Balicer, Martha Skup & Maya Leventer-Roberts. (2018) Is Patient Support Program Participation Associated with Longer Persistence and Improved Adherence Among New Users of Adalimumab? A Retrospective Cohort Study. Advances in Therapy 35:5, pages 655-665.
Crossref
Jérôme Avouac, Anna Moltó, Vered Abitbol, Adrien Etcheto, Axelle Salcion, Loriane Gutermann, Caroline Klotz, Muriel Elhai, Pascal Cohen, Pierre Antoine Soret, Florence Morin, Ornella Conort, François Chast, Claire Goulvestre, Claire Le Jeunne, Stanislas Chaussade, André Kahan, Christian Roux, Yannick Allanore & Maxime Dougados. (2018) Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France. Seminars in Arthritis and Rheumatism 47:5, pages 741-748.
Crossref
Zeren Ma, Xiaoping Liu, Xiaosheng Xu, Jie Jiang, Jian Zhou, Jia Wang, Dewang Chen & Song Luo. (2017) Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis. Medicine 96:25, pages e7145.
Crossref
Carla Bastida, Virginia Ruíz, Mariona Pascal, Jordi Yagüe, Raimon Sanmartí & Dolors Soy. (2017) Is there potential for therapeutic drug monitoring of biologic agents in rheumatoid arthritis?. British Journal of Clinical Pharmacology 83:5, pages 962-975.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.